Alexis Normand is a French entrepreneur, author, and climate-tech executive. He is the co-founder and chief executive officer of Greenly, a Paris-based software company providing automated carbon-accounting and ESG reporting tools. Normand previously worked at Withings and helped co-found the health-data startup Embleema. He is also the author of Prévenir plutôt que guérir : la révolution de la e-santé (Eyrolles, 2017).
Normand was born in France to Nicolas Normand, a French diplomat and former ambassador, and Dominique Normand, an environmental lawyer. He studied business at HEC Paris, political science at Sciences Po, and philosophy at the Sorbonne. After considering a career in public administration, he began in strategy and policy consulting in the Gulf and Egypt, working on urban-planning and demographic projects.
In 2011, Normand joined Withings, where he created the digital-health division and developed partnerships linking connected devices with healthcare providers. After Withings was acquired by Nokia, he relocated to Boston to expand U.S. operations. He later worked at Embleema, a healthcare-data startup, and participated in Techstars New York City.
In 2017, he published Prévenir plutôt que guérir : la révolution de la e-santé (Eyrolles), which advocates for predictive, preventive, participative, and personalized medicine while warning against the risks of surveillance and data misuse.
In 2019, Normand co-founded Greenly with Matthieu Vegreville and Arnaud Delubac. Greenly provides a business-to-business (B2B) software platform for organizations to manage greenhouse-gas accounting. Greenly raised 21 million euros in a Series A round in 2022 and 49 million euros in a Series B round in 2024 led by Fidelity International Strategic Ventures, with participation from Benhamou Global Ventures, Move Capital, HSBC, XAnge, and Energy Impact Partners. He serves as chief executive officer of Greenly.